[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355701-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-355701-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","the-breast-external-validation-of-a-data-driven-algorithm-to-identify-breast-cancer-recurrences-from-administrative-healthcare-data","The Breast - External validation of a data-driven algorithm to identify breast cancer recurrences from administrative healthcare data","","Population-based evidence on breast cancer (BC) recurrence incidence remains limited because tracking relevant clinical information is resource-intensive. This study reports external validation of a data-driven casefinding algorithm designed to identify treatment- and procedure-code signals associated with BC recurrences in administrative healthcare data. A cancer-registry cohort from Emilia-Romagna was linked to hospital discharge and outpatient records, then algorithm outputs were compared with manual clinical chart review over 10 years.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-breast-external-validation-of-a-data-driven-algorithm-to-identify-breast-cancer-recurrences-from-administrative-healthcare-data/355701/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-breast-external-validation-of-a-data-driven-algorithm-to-identify-breast-cancer-recurrences-from-administrative-healthcare-data/355701.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What problem does the study address?","Question",{"text":62,"@type":63},"Population-based data on breast cancer recurrence are scarce because collecting the necessary tracking information is resource-consuming.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How was the algorithm validated?",{"text":67,"@type":63},"The study linked a cancer-registry cohort to administrative hospital discharge and outpatient databases, ran the algorithm, and compared recurrence incidence and timing over 10 years with manual clinical chart review.",{"name":69,"@type":60,"acceptedAnswer":70},"What performance metrics did the algorithm achieve?",{"text":71,"@type":63},"The algorithm showed sensitivity of 92.3%, specificity of 98.0%, positive predictive value of 88.1%, and negative predictive value of 98.8%, each with corresponding confidence intervals reported in the paper.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},355701,1790473587,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","The Breast 87 (2026) 104747  \nContents lists available at ScienceDirect  \nThe Breast  \njournal [homepage:](homepage: www.journals.elsevier.com/the-breast)[ www.journals.elsevier.com/the-breast](homepage: www.journals.elsevier.com/the-breast)  \n| External validation of a data-driven algorithm to identify breast cancer recurrences from administrative healthcare data |  |  | |\n| --- | --- | --- | --- |\n| Silvia Mancini a,1 , Fabiola Giudicib,1, Lauro Bucchia,*,1 , Annibale Biggeric, Orietta Giuliani a, Flavia Baldacchinia, Alessandra Ravaiolia, Federica Zamagnia,\u003Cbr>Federica Toffoluttib, Stefano Guzzinatid, Luigino Dal Masob, Fabio Falcinia,e, Rosa Vattiatoa\u003Cbr>a Emilia-Romagna Cancer Registry, Romagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy b Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy\u003Cbr>c Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy d Epidemiological Department, Azienda Zero, Padua, Italy\u003Cbr>e Cancer Prevention Unit, Local Health Authority, Forlì, Italy |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords: Breast cancer Follow-up Recurrence Algorithm\u003Cbr>Administrative healthcare data |  | Introduction: Population-based data on the incidence of breast cancer (BC) recurrence are scarce, because tracking the relevant information is resource-consuming. We report the external validation of a data-driven casefinding algorithm to identify selected treatment and procedure codes relating to BC recurrences from administrative healthcare data.\u003Cbr>Methods: We linked a cancer registry-based cohort of BC patients from the Emilia-Romagna (northern Italy) regional hospital discharge and outpatient care databases, and we ran the algorithm. We compared the algorithm-determined incidence and temporal pattern of recurrences during 10 years of follow-up with those obtained with a manual clinical chart review.\u003Cbr>Results: The algorithm had a 92.3%(95% confidence interval: 87.2%; 95.8%) sensitivity, a 98.0%(97.0%; 98.8%) specificity, a 88.1%(82.4%; 92.5%) positive predictive value and a 98.8%(97.9%; 99.3%) negative predictive value. The two curves of subhazard rates of total recurrences showed a good degree of overlapping and both exhibited the expected bimodal temporal pattern, with a peak between the 2nd and the 3rd year of followup and another between the 8th and the 9th year. The algorithm-based 10-year cumulative incidence function of recurrence was 15.8%(13.7%; 18.1%) versus 15.0%(13.0%; 17.3%). The algorithm captured with good precision the temporal pattern of recurrence by molecular profile. The design of the algorithm excluded the recurrences (11.1% of the total) detected during the first 12 months (HER2-negative BC) and 24 months (HER2-positive BC) after the diagnosis.\u003Cbr>Conclusions: This validation study demonstrates that identifying breast cancer recurrences from administrative healthcare data is feasible and sufficiently reliable. |  |\n\n1. Introduction  \nPatients treated for breast cancer (BC) face the risk of true recurrences (TRs), that is, local recurrences (LRs), regional recurrences (RRs) and distant metastasis (DM) of the same disease, and the risk of a second independent primary BC (SBC) [1]. The incidence of these events, which is influenced by the prevalence of prognostic factors, is ill-defined because of the limited methodological quality of available  \nevidence. According to studies of sufficient robustness, the competing risk-adjusted 10-year cumulative rate of all types of recurrences combined (LR, RR, DM, and SBC) is around 15%[2,3].  \nFollow-up investigations after the completion of primary treatment aim primarily to detect LRs, RRs and SBCs earlier, that is, to improve survival by detecting and treating recurrent disease while it is still potentially curable with salv","cbCaiqgjbT1zN85q","https://ap.wps.com/l/cbCaiqgjbT1zN85q","pdf",744684,"English","# Introduction\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What problem does the study address?\",\"answer\":\"Population-based data on breast cancer recurrence are scarce because collecting the necessary tracking information is resource-consuming.\"},{\"question\":\"How was the algorithm validated?\",\"answer\":\"The study linked a cancer-registry cohort to administrative hospital discharge and outpatient databases, ran the algorithm, and compared recurrence incidence and timing over 10 years with manual clinical chart review.\"},{\"question\":\"What performance metrics did the algorithm achieve?\",\"answer\":\"The algorithm showed sensitivity of 92.3%, specificity of 98.0%, positive predictive value of 88.1%, and negative predictive value of 98.8%, each with corresponding confidence intervals reported in the paper.\"}]","The Breast - External validation of a data-driven algorithm to identify breast cancer recurrences from administrative healthcare data | PDF",1790120543,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d2f6aa32fc09db57e29f9104c79b899.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/291e5b3d1c8374dfd993e7fc31db3545.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b83ee1fe61d1989a5ee92727837d2aab.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2859a3405a94bd84071e32cc394ae480.webp",980,1306]